Description
A GRK inhibitor (IC50s = 3.9, 0.15, and 0.38 μM for GRK1, GRK2, and GRK5, respectively); selective for GRKs over PKA (IC50 = 120 μM); increases contractility in isoproterenol-stimulated isolated mouse cardiomyocytes at 500 nM; prevents the desensitization of histamine H1 receptor- and purinergic P2Y2 receptor-driven phospholipase C signaling in human ULTR myometrial cells and isolated rat MSMCs, respectively (IC50s = 3.09 and 2.95 μM, respectively)
Formal name: 4-[4-fluoro-3-[[(2-pyridinylmethyl)amino]carbonyl]phenyl]-1,2,3,4-tetrahydro-N-1H-indazol-5-yl-6-methyl-2-oxo-5-pyrimidinecarboxamide
Synonyms:
Molecular weight: 499.5
CAS: 1813527-81-9
Purity: ≥98%
Formulation: A crystalline solid